NCI | Technology Transfer

New Procedure to Block the Replication of Reverse Transcriptase Dependent Viruses by the Use of Inhibitors of Deoxynucleotides Synthesis

Read more about New Procedure to Block the Replication of Reverse Transcriptase Dependent Viruses by the Use of Inhibitors of Deoxynucleotides Synthesis

US Application 11/250,899
Filed on 2005-10-14

Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta

Read more about Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta

Hong Kong
05111097.4
Filed on 2005-12-06

Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo

Read more about Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo

US Application 10/660,369
Filed on 2003-09-11

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 08/223,842
Filed on 1994-04-06

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Patent 5,494,807
Filed on 1993-08-12

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/897,382
Filed on 1992-06-11

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/847,951
Filed on 1992-03-06

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/715,921
Filed on 1991-06-14

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/713,967
Filed on 1991-06-11

A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding

Read more about A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding

Patent Cooperation Treaty
PCT/US2005/047431
Filed on 2005-12-30

Subscribe to NCI